1. 1. A domestic health organization, on or prior to the filing date, shall prepare and submit to the commissioner a report of the health organization’s risk-based capital levels as of the end of the calendar year immediately preceding the filing date, in a form and containing the information required by the risk-based capital instructions. A domestic health organization shall also file its risk-based capital report with the insurance commissioner in each state in which the health organization is authorized to do business, if such insurance commissioner has notified the health organization of its request in writing. Upon receipt of the written request, the health organization shall file its risk-based capital report with the requesting commissioner by no later than the later of the following:

   1. a. Fifteen days from the receipt of the written request.
   2. b. The filing date.

2. 2.

   1. a. A health organization’s risk-based capital shall be determined pursuant to the formula set forth in the risk-based capital instructions. The formula shall take into account all of the following, and may be adjusted, as deemed appropriate by the commissioner, for the covariance between the following:

      1. (1) Assets risk.
      2. (2) Credit risk.
      3. (3) Underwriting risk.
      4. (4) All other business risks and other relevant risks as identified in the risk-based capital instructions.
   2. b. The risk factors shall be applied in the manner set forth in the risk-based capital instructions.
3. 3. A health organization shall seek to maintain capital above the risk-based capital levels required by this chapter.
4. 4. A risk-based capital report filed by a domestic health organization which in the judgment of the commissioner is inaccurate shall be adjusted by the commissioner to correct the inaccuracy. The commissioner shall notify the health organization of the adjustment. The notice shall contain a statement of the reason for the adjustment.

2000 Acts, ch 1050, §3; 2000 Acts, ch 1232, §79

Referred to in §521F.2